About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

ATAC - Bone Density Sub-Protocol | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT00784940

ATAC - Bone Density Sub-Protocol

To assess and quantify the changes in bone mineral density between the ARIMIDEX and ARIMIDEX plus NOLVADEX groups when compared to the NOLVADEX alone treatment group whilst receiving trial therapy.

Lead sponsor: AstraZeneca•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

AstraZeneca

Age

45 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Eligible for entry into the main ATAC trial 1033IL/0029
•Women defined as post-menopausal
•Patients with histologically proven operable invasive breast cancer
•Who following primary surgery have a good prognosis and would be ethically suitable to remain untreated

Exclusion Criteria

•Excluded from entry into the main ATAC trial (1033IL/0029)
•Patients who have received hormone replacement therapy within the previous 12 months prior to randomisation
•Patients who have received bisphosphonate therapy within the previous 12 months prior to randomisation
•Patients who have had a bone fracture within the previous 6 months prior to randomisation

Related studies

RECRUITINGPhase 2

Role of Estrogen on Skeletal Outcomes in FHA

NCT07010146 · Bone Strength, Bone Density, and more

RECRUITINGEARLY Phase 1

Topic Simvastatin for Bone Regeneration

NCT07031778 · Dimensional Changes, Bone Density

Mediating Role of Myokines in the Dialogue Between Muscle and Bone Tissue in a Population of Healthy Women Aged 20-89 Years

NCT06683222 · Bone Density

Enrolling By InvitationPhase 2

Radiographic Assessment of Bone Dimension Around Immediate Implants With FDBA and I-PRF vs FDBA Alone

NCT06522321 · Bone Density Increased

Active Not RecruitingNA

VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL)

NCT04573946 · Bone Density, Bone Health, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 27, 2009Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment308

Start dateJun 1998

Last updatedApr 27, 2009

Condition

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 27, 2009Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions